Christoph Wanner
Universitätsklinikum Würzburg(DE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Lysosomal Storage Disorders Research, Pancreatic function and diabetes
Most-Cited Works
- → Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes(2015)11,755 cited
- → 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice(2021)5,933 cited
- → Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure(2020)4,820 cited
- → Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes(2016)3,564 cited
- → 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension(2023)2,830 cited
- → Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis(2005)2,583 cited
- → A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease